|Active Ingredient||Sildenafil Citrate|
|Starts In||30 minutes to 1 hour|
|Lasts Long||Up to 4 to 5 hours|
How does Aurogra 100mg work
Aurogra 100 mg contains the active ingredient Sildenafil Citrate which is a PDE 5 (Phosphodiesterase Type 5) inhibitor. It relaxes the smooth muscles present in the walls of the blood vessels and improves blood circulation to the penis.
Due to the constriction of the arteries, blood doesn’t flow properly to the penis. Sildenafil Citrate present in Aurogra blocks the action of PDE 5 and enhances nitric oxide (NO)-mediated vasodilation in the corpus cavernosum by inhibiting cGMP breakdown. cGMP (cyclic guanosine monophosphate) is responsible for the contraction and dilation of blood vessels. By enabling the production of cGMP, blood flows properly to the penis. As more and more blood flows to the penis, the pressure is created. This leads to an erection.
Aurogra 100 mg is used for the treatment of the following conditions:
- Erectile Dysfunction (ED) – an inability to achieve or sustain an erection firm enough for sexual intercourse.
- Pulmonary Arterial Hypertension (PAH) – a type of high blood pressure that affects the arteries in the lungs and the heart.
The recommended dose of Aurogra 100 mg is one tablet per day. Do not consume more than one tablet in 24 hours. For best results, it is recommended to take one pill on an empty stomach and approximately 30 minutes to 1 hour before sexual intercourse. The effects of this medicine can be experienced within the first hour of its consumption. However, this may vary from person to person depending on factors such as age, metabolism, medical conditions, etc.
Missed Dose: This medicine is taken as and when needed. Therefore, you are less likely to miss a dose. If you are taking this medicine for the treatment of pulmonary arterial hypertension, take the missed dose as soon as possible. However, if it’s time for your next dose, skip the missed dose and take your next scheduled dose. Do not take double doses to make up for the missed dose.
Overdose: An overdose of the drug can lead to serious side effects. If an overdose is suspected, report it to your doctor immediately.
Aurogra 100 mg pills may not be suitable for you if you suffer from any medical condition. Before you take this medicine, let your doctor know:
- If you are allergic to Sildenafil Citrate or any other medications.
- If you have a history of stroke, congestive heart failure, etc.
- If you suffer from blood cell problems such as sickle cell anemia, leukemia, etc.
- If you suffer from a kidney or liver disease.
- If you have a physical deformity of the penis or Peyronie’s.
- If you have uncontrolled blood pressure.
- If you suffer from conditions such as diabetes, high blood cholesterol, etc.
- If you have an eye-related condition such as retinitis pigmentosa.
- If you take nitrates for chest pain.
- If you suffer from epilepsy or seizures.
- If you are pregnant or breastfeeding.
- If you suffer from ischemic heart disease.
- If you are an alcoholic or have a history of substance abuse.
Discuss your medical history in detail with the doctor.
As with any other medication, there are certain side effects that can occur while taking Aurogra 100 mg tablet. Most of these side effects are temporary and go away after some time.
Rare side effects include:
- Chest pain
- Trouble breathing
- Priapism (a prolonged and painful erection of more than 4 hours)
- NAION (sudden loss of vision in one or both eyes)
This is not a complete list of side effects. If you experience any other side effects after using this drug, contact your doctor.
If you take any OTC drugs, prescription medications, or any vitamins and herbal supplements, let your doctor know about them. Certain medications can interact with Aurogra 100 mg and affect the way it works.
- Alpha-blockers such as alfuzosin and doxazosin
- Oral antifungals such as ketoconazole
- HIV Protease inhibitors such as ritonavir
- Medications for seizures such as carbamazepine
- Anticoagulants such as warfarin
- Beta-blockers such as atenolol
- Other medicines for ED
Discuss potential drug interactions with your doctor.
Interaction with alcohol
Alcohol is known to increase the risk of side effects. You may feel dizzy and your blood pressure may drop suddenly. Avoid consuming alcohol along with this medication.
Interaction with grapefruit juice
Eating grapefruit or drinking grapefruit juice along with Aurogra 100 mg can raise its levels in the body and delay the time it takes for the medication to work.
Aurogra 100 mg tablets should be stored safely in their original packaging.
- Keep the pills away from direct heat, moisture, and sunlight.
- Keep these pills out of reach of children and pets.
- Store these pills at room temperature and in a cool and dry place.
- Do not consume the pills past their expiration date.
Frequently Asked Questions (FAQs)
1. What is Aurogra 100?
Ans. Aurogra 100 is an oral medication prescribed for the treatment of erectile dysfunction in men. It relaxes the smooth muscles present in the walls of the blood vessels and increases the blood flow to the penis. This helps men get or maintain an erection.
2. How to take Aurogra 100?
Ans. This medicine is intended to be taken orally with water. For best results, consume it on an empty stomach and exactly one hour before any sexual activity.
3. Is Aurogra 100 safe?
Ans. Aurogra 100 mg is considered safe and effective for treating erectile dysfunction. If you have a medical history or suffer from any medical condition, consult your doctor before taking this drug.
4. Is Aurogra the same as Viagra?
Ans. Aurogra is the generic version of Viagra and contains the same active ingredient i.e. Sildenafil Citrate.
5. How long does Aurogra 100 last?
Ans. The effects of this medicine last for a period of 4 to 5 hours. The effects may vary for each individual depending on factors such as age, metabolism, medical condition, etc.
- Fink HA, Mac Donald R, Rutks IR, Nelson DB, Wilt TJ. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2002 Jun 24;162(12):1349-60. doi: 10.1001/archinte.162.12.1349. PMID: 12076233. Available from: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/211714
- Loran OB, Ströberg P, Lee SW, Park NC, Kim SW, Tseng LJ, Collins S, Stecher VJ. Sildenafil citrate 100 mg starting dose in men with erectile dysfunction in an international, double-blind, placebo-controlled study: effect on the sexual experience and reducing feelings of anxiety about the next intercourse attempt. J Sex Med. 2009 Oct;6(10):2826-35. doi: 10.1111/j.1743-6109.2009.01428.x. PMID: 19817982. Available from: https://www.jsm.jsexmed.org/article/S1743-6095(15)32273-6/fulltext
- Smith BP, Babos M. Sildenafil. [Updated 2022 May 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK558978/
- Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G; Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005 Nov 17;353(20):2148-57. doi: 10.1056/NEJMoa050010. Erratum in: N Engl J Med. 2006 Jun 1;354(22):2400-1. PMID: 16291984. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa050010
- Sofikitis N, Kaltsas A, Dimitriadis F, Rassweiler J, Grivas N, Zachariou A, Kaponis A, Tsounapi P, Paterakis N, Karagiannis A, Skouros S, Giannakis I, Champilomatis I, Paschopoulos M, Daphnis D, Giakoumakis I, R Gabales M, M Chua JB, Lantin Iii PL, Mamoulakis C, Takenaka A. The Effect of PDE5 Inhibitors on the Male Reproductive Tract. Curr Pharm Des. 2021;27(23):2697-2713. doi: 10.2174/1381612826666200226121510. PMID: 32101115. Available from: https://www.eurekaselect.com/article/104866
- Kim JN, Oh JJ, Park DS, Hong YK, Yu YD. Influence of Alcohol on Phosphodiesterase 5 inhibitors Use in Middle- to Old-Aged Men: A Comparative Study of Adverse Events. Sex Med. 2019 Dec;7(4):425-432. doi: 10.1016/j.esxm.2019.07.004. Epub 2019 Aug 20. PMID: 31444051; PMCID: PMC6963111. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2050116119300935